MustGrow Biologics Corp.
MGROF
$0.47
-$0.02-4.34%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 43.90% | -15.56% | -91.64% | -- | 346,260.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 43.90% | -15.56% | -91.64% | -- | 346,260.00% |
| Cost of Revenue | 2,286.01% | 794.95% | -19.45% | -18.26% | -25.34% |
| Gross Profit | -77.57% | -87.65% | -98.12% | 1,616.64% | 1,483.99% |
| SG&A Expenses | 40.18% | 25.32% | 2.14% | 2.73% | -9.91% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 147.64% | 76.44% | -1.83% | -0.30% | -12.30% |
| Operating Income | -7,053.11% | -2,284.62% | -1,656.29% | 103.77% | 101.28% |
| Income Before Tax | -1,106.26% | -649.02% | -569.54% | 95.26% | 91.73% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1,106.26% | -649.02% | -569.54% | 95.26% | 91.73% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1,106.26% | -649.02% | -569.54% | 95.26% | 91.73% |
| EBIT | -7,053.11% | -2,284.62% | -1,656.29% | 103.77% | 101.28% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -1,157.38% | -616.19% | -511.50% | 97.12% | 92.53% |
| Normalized Basic EPS | -1,128.21% | -612.12% | -517.14% | 97.06% | 92.34% |
| EPS Diluted | -1,157.38% | -616.19% | -511.50% | 97.12% | 92.53% |
| Normalized Diluted EPS | -1,128.21% | -612.12% | -517.14% | 97.06% | 92.34% |
| Average Basic Shares Outstanding | 3.20% | 3.95% | 3.54% | 3.22% | 2.63% |
| Average Diluted Shares Outstanding | 3.20% | 3.95% | 3.54% | 3.22% | 2.63% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |